The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats

about

The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats

Item

http://www.wikidata.org/entity/Q57177116

description

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@en

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@nl

type

Item

label

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@en

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@nl

prefLabel

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@en

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@nl

P1476

The abnormal activation of D1R ...... mine-lesioned Parkinson's rats

@en

P2093

Chen Qi

http://www.w3.org/2001/XMLSchema#string

Jing Gan

http://www.w3.org/2001/XMLSchema#string

Lu Song

http://www.w3.org/2001/XMLSchema#string

Na Wu

http://www.w3.org/2001/XMLSchema#string

Ying Wan

http://www.w3.org/2001/XMLSchema#string

Zhenguo Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications

Dopamine Replacement Therapy, Learning and Reward Prediction in Parkinson's Disease: Implications for Rehabilitation

Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease

An update on the diagnosis and treatment of Parkinson disease

Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum

Presynaptic effects of levodopa and their possible role in dyskinesia.

Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse.

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.

DARPP-32: an integrator of neurotransmission.

P304

1779-1786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S162562

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30013350

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

levodopa

dyskinesia

P932

6038854

http://www.w3.org/2001/XMLSchema#string